Vaccines, Volume 7, Issue 4
2019 December - 96 articles
Cover Story: A novel semisynthetic archaeosome formulation, sulfated S-lactosylarchaeol (SLA), has strong immunostimulatory activity for the induction of antigen-specific immunity following systemic immunization. We evaluated SLA archaeosome formulations as an adjuvant to the E1/E2 HCV envelope protein in a murine model and compared antigen-specific humoral and cellular responses to those generated with mimetics of commercial adjuvants. Overall, we show that the strength and longevity of anti-HCV responses can be influenced by adjuvant selection. In particular, the simple admixed SLA archaeosome formulation generated strong levels of HCV neutralizing antibodies and polyfunctional antigen-specific CD4 T cells, producing multiple cytokines. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.